|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.130 USD | +6.00% |
|
+6.41% | +472.54% |
| 06-15 | Edesa Biotech, Inc. announced that it has received $3.5 million in funding | CI |
| 06-09 | Edesa Biotech, Inc. announced that it expects to receive $3.5 million in funding | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 68.2M | - | - | - | - | - |
| 55.78B | |||||
| 55.66B | |||||
| 23.84B | - | ||||
| 22.7B | - | ||||
| 16.12B |
- Stock Market
- Stocks
- EDSA Stock
- Charts Edesa Biotech, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
